Want to create an interactive transcript for this episode?
Podcast: Surfing the MASH Tsunami
Episode: S3-E53.2 - Serum Metabolomics, Gene Therapy and the Waning Future of Biopsy
Description: Recorded onsite in Washington DC, Scott Friedman, Jörn Schattenberg, Rachel Zayas and Roger Green discuss takeaways from the first three days at the 73rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). The group encapsulates the dynamic, vibrant energy of returning to this momentous event which welcomed back over 7,000 in-person attendees.Jörn starts this conversation by introducing a paper titled, The Effect of a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist, Cotadutide, on Serum Metabolome in Biopsy-Proven Non-Cirrhotic NASH with Fibrosis. He describes Cotadutide followed by the study design which ad...